EX-20 3 g72273aex20.txt PRESS RELEASE Exhibit 20 HCA NEWS -------------------------------------------------------------------------------- FOR IMMEDIATE RELEASE INVESTOR CONTACT MEDIA CONTACT Mark Kimbrough: 615-344-2688 Jeff Prescott: 615-344-5708 HCA REPORTS THIRD QUARTER 2001 EPS Increases 21% to $0.40 vs $0.33 Excluding Gains, Impairments, Restructuring and Investigation Related Costs Earnings Growth Driven by Continued Strength in Volume and Revenue Trends NASHVILLE, TENN., OCTOBER 24, 2001 - HCA (NYSE: HCA) today announced operating results for the third quarter and nine months ended September 30, 2001. "The Company continued to experience strong patient volume and revenue growth during the third quarter," stated Jack O. Bovender, Jr., HCA's CEO and President. "The results are particularly impressive considering that we are comparing to a very strong third quarter of 2000 where same facility admission growth exceeded 4 percent." During the third quarter of 2001, revenues increased to $4.4 billion, up 8.4 percent from $4.1 billion in the third quarter of 2000. Net income, excluding gains on sales of facilities, impairment of long-lived assets, restructuring of operations and investigation related costs, totaled $209 million or $0.40 per diluted share for the third quarter of 2001, compared to $186 million or $0.33 per diluted share in the third quarter of 2000. Net income for the third quarter of 2001 totaled $256 million or $0.48 per diluted share, compared to $174 million or $0.31 per diluted share in the third quarter of 2000. 1 The 2001 third quarter operating results includes a $16 million charge to Other Operating Expense, or $0.02 per share, for settlement of non-governmental litigation related to 1997 business matters. For the quarter ended September 30, 2001, same facility revenues increased 10.8 percent. Same facility admissions for the Company's hospitals increased by 2.6 percent during the quarter. Same facility inpatient revenue per admission increased in the quarter by 8.3 percent and same facility revenue per equivalent admission increased 8.1 percent. Excluding the amortization of goodwill, net income (excluding gains on sales of facilities, impairment of long-lived assets, restructuring of operations and investigation related costs) was $226 million or $0.43 per diluted share in the third quarter of 2001 compared to $207 million or $0.36 per diluted share for the third quarter of 2000. During the quarter ended September 30, 2001, the Company recorded gains on sales of facilities totaling $112 million ($68 million net of tax) or $0.13 per diluted share. Also during the quarter, the Company recorded asset impairment charges of $17 million ($10 million net of tax) or $0.02 per diluted share. Revenues for the nine months ended September 30, 2001, totaled $13.4 billion compared to $12.5 billion in the first nine months of 2000. Net income, before settlement with Federal government, gains on sales of facilities, impairment of long-lived assets and restructuring of operations and investigation related costs, totaled $811 million or $1.49 per diluted share in the first nine months of 2001, compared to $715 million or $1.26 per diluted share for the nine months ended September 30, 2000. Net income totaled $845 million or $1.56 per diluted share in 2001 versus $198 million or $0.35 per diluted share in 2000. For the nine months ended September 30, 2001, HCA recognized gains on sales of facilities of $125 million ($72 million net of tax) or $0.13 per diluted share and asset impairment charges of $17 million ($ 10 million net of tax) or $0.02 per diluted share. As of September 30, 2001, the Company operated 189 hospitals and 78 outpatient surgery centers (including 7 hospitals and 3 surgery centers owned through 50/50 equity joint ventures), compared to 198 hospitals and 79 outpatient surgery centers 2 (including 9 hospitals and 3 surgery centers owned through equity joint ventures) at September 30, 2000. At September 30, 2001, the Company's balance sheet reflected total debt of $7.1 billion, common, temporary and minority equity of $6.0 billion and total assets of $17.5 billion. Capital expenditures for the quarter totaled $371 million. The Company's total debt-to-capital ratio was 54 percent at September 30, 2001. HCA will host a conference call for investors at 8:30 a.m. CST today. All interested investors are invited to access a live audio broadcast of the call, via Webcast. The broadcast also will be available on a replay basis beginning this afternoon and throughout the next 30 days. The Webcast can be accessed at www.videonewswire.com/event.asp?id=1445 or via the Investor Relations site at www.hcahealthcare.com. * * * This press release contains forward-looking statements based on current management expectations. Numerous risks, uncertainties and other factors including: (i) the outcome of the known and unknown governmental investigations and litigation involving the Company's business practices including the ability to negotiate, execute and timely consummate definitive settlement agreements in the government's remaining civil cases and to obtain court approval thereof, (ii) the highly competitive nature of the health care business, (iii) the efforts of insurers, health care providers and others to contain health care costs, (iv) possible changes in the Medicare and Medicaid programs that may impact reimbursements to health care providers and insurers, (v) changes in Federal, state or local regulation affecting the health care industry, (vi) the possible enactment of Federal or state health care reform, (vii) the ability to attract and retain qualified management and personnel, including affiliated physicians, nurses and medical support personnel, (viii) liabilities and other claims asserted against the Company, (ix) fluctuations in the market value of the Company's common stock, (x) ability to complete the share repurchase program, (xi) changes in accounting practices, (xii) changes in general economic conditions, (xiii) future divestitures which may result in additional charges, (xiv) changes in revenue mix and the ability to enter into and renew managed care provider arrangements on acceptable terms, (xv) the availability and terms of capital to fund the expansion of the Company's business, (xvi) changes in business strategy or development plans, (xvii) slowness of reimbursement, (xviii) the ability to implement the Company's shared services and other initiatives and realize decreases in administrative, supply and infrastructure costs, (xix) the outcome of pending and any future tax audits and litigation associated with the Company's tax positions, (xx) the outcome of the Company's continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures and the Company's corporate integrity agreement with the government, (xxi) increased reviews of the Company's cost reports, (xxii) the ability to maintain and increase patient volumes and control the costs of providing services, and (xxiii) other risk 3 factors detailed from time to time in the Company's filings with the SEC may cause actual results to differ materially from these anticipated in the forward looking statements. Many of the factors that will determine the Company's future results are beyond the ability of the Company to control or predict. Readers should not place undue reliance on forward-looking statements, which reflect management's views only as of the date hereof. The Company undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. All references to "Company" and "HCA" as used throughout this document refer to HCA Inc. and its affiliates. 4 HCA INC. Consolidated Operating Results Summary (Dollars in millions, except per share amounts)
For the Nine Months Ended Third Quarter September 30, ---------------- ------------------- 2001 2000 2001 2000 ------ ------ ------- ------- Revenues ............................................................................ $4,438 $4,093 $13,415 $12,497 EBITDA (a) .......................................................................... $770 $736 $2,618 $2,441 Net income: Excluding settlement with Federal government, gains on sales of facilities, impairment of long-lived assets and restructuring of operations and investigation related costs ................................................. $209 $186 $811 $715 Settlement with Federal government (net of tax) ................................ -- -- (1) (498) Gains on sales of facilities (net of tax) ...................................... 68 9 72 18 Impairment of long-lived assets (net of tax) ................................... (10) (12) (10) (12) Restructuring of operations and investigation related costs (net of tax) ....... (11) (9) (27) (25) ------------------ ---------------------- Net income .................................................................... $256 $174 $845 $198 ================ ====================== Diluted earnings per share: Excluding settlement with Federal government, gains on sales of facilities, impairment of long-lived assets and restructuring of operations and investigation related costs ................................................. $0.40 $0.33 $1.49 $1.26 Settlement with Federal government ............................................. -- -- -- (0.88) Gains on sales of facilities ................................................... 0.13 0.02 0.13 0.03 Impairment of long-lived assets ................................................ (0.02) (0.02) (0.02) (0.02) Restructuring of operations and investigation related costs ................... (0.03) (0.02) (0.04) (0.04) ------------------ ---------------------- Net income ..................................................................... $0.48 $0.31 $1.56 $0.35 ================== ====================== Shares used in computing diluted earnings per share (000) ........................... 529,491 566,470 543,274 568,216
-------------------------------- (a) EBITDA is defined as income before depreciation and amortization, interest expense, settlement with Federal government, gains on sales of facilities, impairment of long-lived assets, restructuring of operations and investigation related costs, minority interests and income taxes. 5 HCA INC. Consolidated Income Statements Third Quarter (Dollars in Millions, Except Per Share Amounts)
2001 2000 ------------------ ----------------- Amount Ratio Amount Ratio ------ ----- ------ ----- Revenues ............................................................... $4,438 100.0 % $4,093 100.0 % Salaries and benefits .................................................. 1,808 40.7 1,650 40.3 Supplies ............................................................... 712 16.0 646 15.8 Other operating expenses ............................................... 824 18.6 756 18.5 Provision for doubtful accounts ........................................ 364 8.2 333 8.1 Equity in earnings of affiliates ....................................... (40) (0.9) (28) (0.7) ------------------------ ----------------------- 3,668 82.6 3,357 82.0 ------------------------ ----------------------- EBITDA ............................................................. 770 17.4 736 18.0 Depreciation and amortization .......................................... 255 5.7 257 6.3 Interest expense ....................................................... 137 3.1 147 3.6 Gains on sales of facilities ........................................... (112) (2.5) (20) (0.5) Impairment of long-lived assets ........................................ 17 0.4 17 0.4 Restructuring of operations and investigation related costs ............ 17 0.4 16 0.4 ------------------------ ----------------------- Income before minority interests and income taxes ...................... 456 10.3 319 7.8 Minority interests in earnings of consolidated entities ................ 33 0.8 26 0.6 ------------------------ ----------------------- Income before income taxes ............................................. 423 9.5 293 7.2 Provision for income taxes ............................................. 167 3.7 119 2.9 ------------------------ ----------------------- Net income ......................................................... $256 5.8 $174 4.3 ======================== ======================= Diluted earnings per share: Excluding gains on sales of facilities, impairment of long-lived assets and restructuring of operations and investigation related costs .............................. $0.40 $0.33 Gains on sales of facilities ....................................... 0.13 0.02 Impairment of long-lived assets .................................... (0.02) (0.02) Restructuring of operations and investigation related costs ........ (0.03) (0.02) ------------ ------------ Net income ......................................................... $0.48 $0.31 ============ ============ Shares used in computing diluted earnings per share (000) .............. 529,491 566,470
6 HCA INC. Consolidated Income Statements For the Nine Months Ended September 30, 2001 and 2000 (Dollars in Millions, Except Per Share Amounts)
2001 2000 ------------------- ------------------- Amount Ratio Amount Ratio ------- ----- ------- ----- Revenues ................................................................ $13,415 100.0 % $12,497 100.0 % Salaries and benefits ................................................... 5,412 40.3 4,956 39.7 Supplies ................................................................ 2,136 15.9 1,971 15.8 Other operating expenses ................................................ 2,381 17.8 2,288 18.2 Provision for doubtful accounts ......................................... 990 7.4 934 7.5 Equity in earnings of affiliates ........................................ (122) (0.9) (93) (0.7) ------------------- ------------------------ 10,797 80.5 10,056 80.5 ------------------- ------------------------ EBITDA .............................................................. 2,618 19.5 2,441 19.5 Depreciation and amortization ........................................... 774 5.8 778 6.2 Interest expense ........................................................ 418 3.1 402 3.2 Settlement with Federal government ...................................... 2 -- 745 6.0 Gains on sales of facilities ............................................ (125) (0.9) (38) (0.3) Impairment of long-lived assets ......................................... 17 0.1 17 0.1 Restructuring of operations and investigation related costs ............. 44 0.3 41 0.3 ------------------- ------------------------ Income before minority interests and income taxes ....................... 1,488 11.1 496 4.0 Minority interests in earnings of consolidated entities ................. 92 0.7 81 0.7 ------------------- ------------------------ Income before income taxes .............................................. 1,396 10.4 415 3.3 Provision for income taxes .............................................. 551 4.1 217 1.7 ------------------- ------------------------ Net income .......................................................... $845 6.3 $198 1.6 =================== ======================== Diluted earnings per share: Excluding settlement with Federal government, gains on sales of facilities, impairment of long-lived assets and restructuring of operations and investigation related costs.................. $1.49 $1.26 Settlement with Federal government .................................. -- (0.88) Gains on sales of facilities ........................................ 0.13 0.03 Impairment of long-lived assets ..................................... (0.02) (0.02) Restructuring of operations and investigation related costs ......... (0.04) (0.04) ----------- ------------ Net income .......................................................... $1.56 $0.35 =========== ============ Shares used in computing diluted earnings per share (000) ............... 543,274 568,216
7 HCA INC. Consolidated Balance Sheets (Dollars in Millions)
September 30, June 30, December 31, 2001 2001 2000 ------------- -------- ------------ ASSETS Current assets: Cash and cash equivalents ................................. $ 74 $ 124 $ 314 Accounts receivable, net .................................. 2,398 2,364 2,211 Other ..................................................... 1,769 1,891 1,928 --------- --------- --------- Total current assets ................................. 4,241 4,379 4,453 Property and equipment, at cost ................................ 14,984 14,695 14,290 Accumulated depreciation ....................................... (6,280) (6,130) (5,810) --------- --------- --------- 8,704 8,565 8,480 Investments of insurance subsidiary ............................ 1,408 1,529 1,371 Investments in and advances to affiliates ...................... 698 831 779 Intangible assets, net of accumulated amortization ............. 2,032 2,170 2,155 Other .......................................................... 414 406 330 --------- --------- --------- $ 17,497 $ 17,880 $ 17,568 ========= ========= ========= LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable .......................................... $ 680 $ 673 $ 693 Other current liabilities ................................. 1,338 1,317 1,487 Government settlement accrual ............................. -- 745 840 Long-term debt due within one year ........................ 795 218 1,121 --------- --------- --------- Total current liabilities ............................ 2,813 2,953 4,141 Long-term debt ................................................. 6,312 6,857 5,631 Professional liability risks, deferred taxes and other liabilities ......................................... 2,354 2,313 2,050 Minority interests in equity of consolidated entities .......... 603 596 572 Company-obligated mandatorily redeemable securities of affiliate holding solely Company securities ............... 500 300 -- Forward purchase contracts and put options ..................... -- -- 769 Stockholders' equity ........................................... 4,915 4,861. 4,405 --------- --------- --------- $ 17,497 $ 17,880 $ 17,568 ========= ========= ========= Current ratio .................................................. 1.51 1.48 1.08 Ratio of debt to debt plus common, temporary and minority equity 54.1% 55.1% 54.0% Shares outstanding (thousands) ................................. 514,845 518,223 542,992
8 HCA INC. Operating Statistics
For the Nine Months Third Quarter Ended September 30, ------------------------------- ------------------------------- 2001 2000 2001 2000 ---------- ---------- ---------- ---------- CONSOLIDATED HOSPITALS: Number of Hospitals 182 189 182 189 Weighted Average Licensed Beds 40,458 41,409 40,752 41,837 Licensed Beds at End of Period 40,450 41,298 40,450 41,298 Admissions 380,800 381,200 1,181,300 1,169,900 Same Facility % Change 2.6% 3.0% Equivalent Admissions 567,000 568,500 1,741,300 1,735,000 Same Facility % Change 2.5% 2.6% Revenue per Equivalent Admission $ 7,827 $ 7,198 $ 7,704 $ 7,203 Same Facility % Change 8.1% 6.7% Inpatient Revenue per Admission $ 7,109 $ 6,479 $ 6,943 $ 6,378 Same Facility % Change 8.3% 8.7% Patient Days 1,873,400 1,842,600 5,851,400 5,775,800 Equivalent Patient Days 2,789,300 2,748,300 8,625,000 8,565,500 Emergency Room Visits 1,160,000 1,135,900 3,511,300 3,411,400 Same Facility % Change 5.2% 6.5% Outpatient Revenues as a Percentage of Patient Revenues 37.3% 37.0% 37.0% 37.1% Average Length of Stay 4.9 4.8 5.0 4.9 Occupancy 50.3% 48.4% 52.6% 50.4% Equivalent Occupancy 74.9% 72.3% 77.5% 74.7% NUMBER OF CONSOLIDATED AND NON-CONSOLIDATED (50/50 EQUITY JOINT VENTURES) HOSPITALS: Consolidated 182 189 182 189 Non-Consolidated (50/50 Equity Joint Ventures) 7 9 7 9 ---------- ---------- ---------- ---------- Total Number of Hospitals 189 198 189 198 ========== ========== ========== ==========
9